PharmaShots Weekly Snapshots (April 29 – May 03, 2024)
This week PharmaShots’ news was all about the updates on M&A, Pharma, Clinical Trials, Regulatory & MedTech. Check out our full report below:
Daiichi Sankyo and AstraZeneca Report the P-III (DESTINY-Breast06) Study Data of Enhertu to Treat Breast Cancer
Read More: Daiichi Sankyo & AstraZeneca
Merck Reports Data from the P-III (STRIDE-10) Trial of V116 Pneumococcal Conjugate Vaccine for Adults
Read More: Merck
Veru Reports First Patient Enrollment in the P-IIb Study of Enobosarm Plus Semaglutide for High Quality Weight Loss
Read More: Veru
Jacobio Pharma Reports Data from the P-II Study of Glecirasib for Treating Non-Small Cell Lung Cancer
Read More: Jacobio Pharma
Merck Reports the P-III (KEYNOTE-811) Study Data of Keytruda Plus Trastuzumab and Chemotherapy for G/GEJ Adenocarcinoma
Read More: Merck
AstraZeneca Reports Data from the P-III (ECHO) Study of Calquence Combination Regimen for Mantle Cell Lymphoma
Read More: AstraZeneca
Aileron Therapeutics Reports Cohort 1 Results from the P-Ib Study of LTI-03 for Idiopathic Pulmonary Fibrosis (IPF)
Read More: Aileron Therapeutics
Boehringer Ingelheim Collaborates with Walgreens to Improve Clinical Trials Access
Read More: Boehringer Ingelheim & Walgreens
Remix Therapeutics Reports First Patient Dosing in Two of REM-422’s P-I Studies for Treating ACC and AML or High-Risk MDS
Read More: Remix Therapeutics
Organogenesis Reports the P-III Study Data of ReNu for Knee Osteoarthritis
Read More: Organogenesis
The US FDA Approves the Label Update of Gilead’s Biktarvy for Pregnant Adults with HIV
Read More: Gilead
Takeda’s Fruquintinib Gains the CHMP’s Positive Opinion for Previously Treated Metastatic Colorectal Cancer
Read More: Takeda
AstraZeneca’s Truqap Plus Faslodex Receives the CHMP’s Positive Opinion for Treating Breast Cancer
Read More: AstraZeneca
Johnson & Johnson’s Sirturo Gains the CHMP’s Positive Opinion to Treat Multidrug-Resistant Tuberculosis
Read More: Johnson & Johnson
X4 Pharmaceuticals’ Xolremdi Receives the US FDA’s Approval for the Treatment of WHIM Syndrome
Read More: X4 Pharmaceuticals
Taysha Gene Therapies’ TSHA-102 Receives the US FDA’s Regenerative Medicine Advanced Therapy Designation for Rett Syndrome
Read More: Taysha Gene Therapies
Amolyt Pharma’s Eneboparatide Receives the US FDA’s Fast Track Designation for Hypoparathyroidism
Read More: Amolyt Pharma
Repertoire Immune Medicines and BMS Partner to Develop Tolerizing Vaccines for Autoimmune Diseases
Read More: Repertoire Immune Medicines & BMS
Bayer and Evotec Join Forces to Develop Treatment for Cardiovascular Diseases
Read More: Bayer & Evotec
PeptiDream Expands its Partnership with Novartis for Peptide Discovery
Read More: Novartis & PeptiDream
G1 Therapeutics Partners with Pepper Bio for Lerociclib
Read More: G1 Therapeutics & Pepper Bio
Astellas Collaborates with Poseida Therapeutics to Develop New Allogeneic Cell Therapies in Oncology
Read More: Astellas Collaborates & Poseida Therapeutics
Abbott's Esprit BTK System Gains the US FDA’s Approval for Chronic Limb-Threatening Ischemia (CLTI) Below-The-Knee (BTK)
Read More: Abbott
Natera Introduces Fetal RhD NIPT Test to Aid Physicians and Patients During RhIg Shortage
Read More: Natera
ONO Pharmaceutical Reports Acquisition of Deciphera Pharmaceuticals for $2.4B
Read More: ONO Pharmaceutical & Deciphera Pharmaceuticals
Harmony Biosciences Expands its CNS Pipeline Through the Acquisition of Epygenix Therapeutics
Read More: Harmony Biosciences & Epygenix Therapeutics
Quest Diagnostics Reports the Acquisition of PathAI Diagnostics to Enhance Cancer Diagnosis
Read More: Quest Diagnostics & PathAI Diagnostics
Novartis to Acquire Mariana Oncology, Expanding its Radioligand Therapy Pipeline
Read More: Novartis & Mariana Oncology
Zoetis Reports Divestiture of its Medicated Feed Additive Portfolio to Phibro Animal Health
Read More: Zoetis
The US FDA Approves High Concentration of Boehringer Ingelheim's Cyltezo (Biosimilar, Humira)
Read More: Boehringer Ingelheim
Related Post:- PharmaShots Weekly Snapshots (April 22 – April 26, 2024)
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.